There have been PostExposure Prophylaxis (PEP) studies completed on healthy individuals who may have been exposed to infection and not hospitalized to see if hydroxychloroquine prevents getting covid, both very large but neither showed a benefit. There is also a Pre Exposure Prophylaxis (PrEP) study, also quite large, still in progress to see if the drug might prevent infection in individuals who have not been exposed but might. That's still in progress with results expected soon.Can you explain why they only conducted "studies" on hospitalized patients, who we know are in grave danger once they enter the hospital? Why haven't they studied it's use (along with zinc and/or azithromycin) on mildly symptomatic patients to keep them from reaching the hospital?
Here's a decent summary of the current state of hydroxychloroquine research:
Three big studies dim hopes that hydroxychloroquine can treat or prevent COVID-19
https://www.sciencemag.org/news/202...roxychloroquine-can-treat-or-prevent-covid-19